Intrexon Corp (NYSE:XON)

14.64
Delayed Data
As of 4:02pm ET
 +0.08 / +0.55%
Today’s Change
10.26
Today|||52-Week Range
23.84
+27.08%
Year-to-Date

Today’s Trading

Previous close14.56
Today’s open14.51
Day’s range14.51 - 14.91
Volume989,983
Average volume (3 months)1,405,577
Market cap$2.0B
Data as of 4:02pm ET, 07/17/2018

Growth & Valuation

Earnings growth (last year)+37.97%
Earnings growth (this year)-1,133.79%
Earnings growth (next 5 years)-78.25%
Revenue growth (last year)+20.98%
P/E ratioNM
Price/Sales5.98
Price/Book3.53

Competitors

 Today’s
change
Today’s
% change
BPMCBlueprint Medicines ...-0.01-0.01%
HALOHalozyme Therapeutic...+0.17+0.99%
----
ONCESpark Therapeutics I...+4.25+5.11%
Data as of 4:00pm ET, 07/17/2018

Financials

Next reporting dateAugust 15, 2018
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$231.0M
Annual profit (last year)-$117.0M
Net profit margin-50.66%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Randal J. Kirk
Chief Operating Officer
Thomas Bostick
Corporate headquarters
Germantown, Maryland

Forecasts